Wolverine Trading, LLC Reata Pharmaceuticals Inc Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 23, 2023	BUY	$79.22 - $105.37 $1.77 Million - $2.35 Million	22,300 Added 210.38%	32,900 $3.35 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $327,010 - $987,602	10,600 New	10,600 $954,000
Q1 2020 May 11, 2020	SELL	$124.16 - $247.74 $931,200 - $1.86 Million	-7,500 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$74.57 - $217.92 $223,709 - $653,760	3,000 Added 66.67%	7,500 $1.53 Million
Q2 2019 Aug 20, 2019	BUY	$77.72 - $94.35 $349,740 - $424,575	4,500 New	4,500 $425,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.